Opus Genetics, Inc. (IRD) Return on equity 2021–2025
Opus Genetics, Inc. (IRD) return on equity by fiscal year — reported net income divided by year-end shareholders’ equity.
-323.1%FY2025 · since FY2021: -255.1% → -323.1%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -323.1% | +532.5 pp |
| FY2024 | -855.6% | -835.6 pp |
| FY2023 | -20.0% | -58.7 pp |
| FY2022 | 38.7% | +293.8 pp |
| FY2021 | -255.1% | — |
ROE = reported net income ÷ reported year-end shareholders’ equity for the same fiscal year. Heavy buybacks shrink equity and can push ROE very high (or negative-equity years drop out).
Source: SEC XBRL filings · For reference only · Not investment advice